dia 2022

Greenphire talks clinical trial challenges at DIA Global Annual Meeting

By Jenni Spinner

- Last updated on GMT

(sesame/iStock via Getty Images Plus)
(sesame/iStock via Getty Images Plus)

Related tags DIA Greenphire Clinical trials Patient recruitment Patient centricity Clinical research

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

Greenphire, a company centered on financial lifecycle management technology for clinical studies, discussed its range of offerings aimed at helping clinical research operations better streamline their studies. For example, its EnvisiX technology, first launched two years ago, is intended to streamline the budgeting process via access to up-to-date, fair-market-value data for clinical trials around the globe; according to the company, contract research organizations (CROs) in North America, Europe, Latin America, and Asia, have seen improvements in workflow, collaboration, and transparency.

Clareece West, executive vice president for commercial operations, Linical

Linical (a full-spectrum, multinational CRO) was among EnvisiX’s early adopters. Clareece West, executive vice president for commercial operations at Linical, said, “We are excited to partner with Greenphire, enabling access to the most robust and contemporary investigator grant negotiated actuals data in the industry. This data, along with the ease of building a budget through a simple and flexible tool, brings considerable value to our clients’ clinical development programs​."

Ashley Baxter, Greenphire’s clinical pricing analyst, presented a session at DIA, “Optimizing Study Budgeting and Access to Industry Indicative FMV Data to Accelerate Trial Timelines​” on June 22.

Ashley Baxter, clinical pricing analyst, Greenphire

Regardless of study size or resources of the sponsor initiating a study, building and negotiating an appropriate budget continues to be one of the most complex, time-consuming, and costly aspects of a clinical trial​,” Baxter said. “I am honored to share how tools like Greenphire’s EnvisiX, are able to optimize and simplify the process through an intuitive workflow and access to real-time FMV data.​”


Related news

Show more

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us


View more